论文部分内容阅读
为明确放疗、化疗不同的治疗搭配方式在局部晚期非小细胞肺癌(NSCLC)治疗中的作用及毒性反应,作者报道了RTOG随机性研究的结果。 自1992年7月~1994年2月,共168例NSCLS病人进入该项随机性研究。所有病人均经组织学或细胞学证实,分期标准按照Mountain提出的国际新分期,则包括由于内科原因不能手术的Ⅱ期病人,及局部晚期不能手术切除的Ⅲ_A、Ⅲ_B病人。
To clarify the role and toxicity of radiotherapy and chemotherapy in the treatment of locally advanced non-small cell lung cancer (NSCLC), the authors report the results of a randomized RTOG study. From July 1992 to February 1994, a total of 168 NSCLS patients entered the randomized study. All patients were confirmed by histology or cytology. According to Mountain’s new international staging criteria, stage II patients included patients who could not be operated for medical reasons, and those patients with locally advanced III-A and III_B patients who could not be surgically resected.